These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6935177)

  • 1. Mutagenesis assays with mammalian cells.
    Kuroki T; Abbondandolo A; Drevon C; Huberman E; Laval F
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):107-33. PubMed ID: 6935177
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro metabolic activation in genotoxicity assays with mammalian cell cultures.
    Belvedere G
    Boll Chim Farm; 1985 Feb; 124(2):57-68. PubMed ID: 4015867
    [No Abstract]   [Full Text] [Related]  

  • 3. Basic requirements for in vitro metabolic activation systems in mutagenesis testing.
    Wood AW; Bartsch H; Fishbein L; Garattini S; Gielen J; Malaveille C; Roberfroid M; Teichman B; Vesell E
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):277-94. PubMed ID: 6935183
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutagenesis assays with bacteria.
    Davis A; Devoret R; Green M; Hofnung M; Kawachi T; Matsushima T; McCann J; Mohn GR; Norpoth K; Radman M; Rosenkranz HS; Venitt S
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):85-106. PubMed ID: 6450174
    [No Abstract]   [Full Text] [Related]  

  • 5. Problems associated with the metabolic activation of carcinogens and mutagens in short-term tests.
    Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():133-47. PubMed ID: 7030701
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutagenesis assays with yeasts and moulds.
    Loprieno N; von Borstel RC; Herrera L; de Serres FJ
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):135-55. PubMed ID: 6450173
    [No Abstract]   [Full Text] [Related]  

  • 7. Rationale for deployment of short-term assays for evidence of carcinogenicity.
    Drake JW; de Serres FJ; Darby WJ; Dunkel VC; Longfellow DG; Ott H; Purchase IF; Ramel C; Schlatter C; Smith EM
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):295-308. PubMed ID: 6935184
    [No Abstract]   [Full Text] [Related]  

  • 8. Incorporation of mammalian metabolism into mutagenicity testing.
    Malling HV
    Mutat Res; 2004 May; 566(3):183-9. PubMed ID: 15082236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of assay systems for drug-resistant mutation in cultured mammalian cells.
    Ochi T; Umeda M
    Jpn J Exp Med; 1981 Jun; 51(3):141-7. PubMed ID: 7300029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial and mammalian mutagenicity tests: validation and comparative studies on 180 chemicals.
    Bartsch H; Malaveille C; Camus AM; Martel-Planche G; Brun G; Hautefeuille A; Sabadie N; Barbin A; Kuroki T; Drevon C; Piccoli C; Montesano R
    IARC Sci Publ; 1980; (27):179-241. PubMed ID: 7002778
    [No Abstract]   [Full Text] [Related]  

  • 11. The induction of mutation and differentiation in mammalian cells by chemicals which initiate or promote tumor formation.
    Huberman E
    Dev Toxicol Environ Sci; 1980; 8():121-32. PubMed ID: 7030700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization of conditions for the metabolic activation of N-nitrosodiethylamine in mutagenicity tests.
    Aiub CA; Pinto LF; Felzenszwalb I
    Genet Mol Res; 2004 Jun; 3(2):264-72. PubMed ID: 15266397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotoxicity produced in cultured mammalian cell assays by treatment conditions. A symposium. June 9, 1986, Amsterdam. Proceedings.
    Mutat Res; 1987 Sep; 189(1):1-79. PubMed ID: 3627147
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutagenesis assays with whole mammals.
    Russell LB; Elias P; Matter BE; Sullivan F
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):245-76. PubMed ID: 6935182
    [No Abstract]   [Full Text] [Related]  

  • 16. Mutagenicity detection with human cells.
    DeMars R; Jackson JL
    J Environ Pathol Toxicol; 1977; 1(2):55-77. PubMed ID: 553143
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vivo and in vitro studies of mutagenic properties of carcinogenic N-nitramines].
    Khudoleĭ VV; Malaveille C; Bartsch H
    Vopr Onkol; 1981; 27(11):59-62. PubMed ID: 7039103
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term and short-term screening assays for carcinogens: a critical appraisal.
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):1-426. PubMed ID: 6935176
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutation research, genetic toxicology and environmental mutagenesis.
    Martus HJ; Suter W
    Mutat Res; 2009 Jan; 672(2):135. PubMed ID: 19056513
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
    Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
    Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.